Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: Studies with A-77636

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 1022-1029

  Lin, Chun Wel ^a   Bianchi, Bruce R ^a   Miller, Thomas R ^a   Stashko, Michael A ^a   Wang, Song S ^a,b   Curzon, Peter ^a   Bednarz, Lisa ^a   Asin, Karen E ^a   Britton, Donald R ^a  

^a ABBOTT LABORATORIES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADAMANTANE; BENZOPYRAN DERIVATIVE; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE;

ANIMAL; ARTICLE; BINDING COMPETITION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; METABOLISM; RADIOASSAY; RAT; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADAMANTANE; ANIMALS; BENZOPYRANS; BINDING, COMPETITIVE; CELLS, CULTURED; CYCLIC AMP; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1;

EID: 0030111239     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ASIN, K. E. AND WIRTSHAFTER, D.: Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression. Eur. J. Pharmacol. 235: 167-168, 1993.
2. ASIN, K. E., BEDNARZ, L., NIKKEL, A. AND PERNER, R.: Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa. J. Pharmacol. Exp. Ther. 273: 1483-1490, 1995.
3. BALMFORTH, A. J., WARBURTON, P. AND BALL, S. G.: Homologous desensitization of the D1 dopamine receptor. J. Neurochem. 55: 2111-2116, 1990.
4. BARTON, A. C. AND SIBLEY, D. R.: Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. Mol. Pharmacol. 38: 531-541, 1990.
5. BATES, M. D., OLSEN, C. L., BECKER, B. N., ALBERS, F. J., MIDDLETON, J. P., MULHERON, J. G., JIN, S. L. C., CONTI, M. AND RAYMOND, J. R.: Elevation of cAMP is required for down-regulation, but not agonist-induced desensitization, of endogenous dopamine D1 receptors in opossum kidney cells. J. Biol. Chem. 268: 14757-14763, 1993.
6. BLANCHET, P., BEDARD, P. J., BBITTON, D. R. AND KEBABIAN, J. W.: Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopainduced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J. Pharmacol. Exp. Ther. 267: 275-279, 1993.
7. BRITTON, D. R., KEBABIAN, J. W. AND CURZON, P.: Rapid reversal of supersensitivity of denervated D1 receptors by 1-dopa or a novel D1 agonist, A68930. Eur. J. Pharmacol. 200: 89-93, 1991.
8. CEDARBAUM, J. M. AND SCHLEIFER, L S.: Drugs for Parkinson's disease, spasticity, and acute muscle spasm. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor, 8th ed., pp. 463-484, Pergamon Press, New York, 1990.
9. CHNEIWEISS, H. GLOWINSKI, J. AND PREMONT, J.: Dopamine-induced homologuous and heterologous desensitizations of adenylate cyclase-coupled receptors on striatal neurons. Eur. J. Pharmacol. 189: 287-292, 1990.
10. GOLBE, L. I., LIEBERMAN, A. N., MUENTER, M. D., Foss, S.-H. AND DUVOISIN, R. C.: Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease. Clin, Neuropharmacol. 11: 45-55, 1988.
11. GRONDIN, R., BLANCHET, P. J , BEDARD, P. J , BRITTON, D. R., SHIOSAKI, K. AND KEBABIAN, J. W.: Dramatic desensitzation of the behavioral response to a long-acting D1 but not D2 agonist in MPTP monkeys. Soc. Neurosci. Abst. 20: 1645, 1994.
12. GUPTA, S. K. AND MISHRA, R. K.: Desensitization of D1 dopamine receptors down-regulates the Gsa subunit of G protein in SK-N-MC neuroblastoma cells. J. Mol. Neurosci. 4: 117-123, 1993.
13. KHAC, L. D., SANDRINE, N. AND HARBON, S.: Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: stimulation and desensitization. Mol. Pharmacol. 46: 485-494, 1994.
14. KEBABIAN, J. W., BRITTON, D. R., DENINNO, M. P., PERNER, R., SMITH, L., JENNER, P., SCHOENLEBER, R. AND WILLIAMS, M.: A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsoman activity in marmosets. Eur. J. Pharmacol. 229: 203-209, 1992.
15. LEFKOWITZ, R. J.: G protein-coupled receptor kinases. Cell 74: 409-412, 1993.
16. 1 receptor-mediated calcium release in 293 cells. Mol. Pharmacol. 47: 131-139, 1995.
17. OFORI, S., BUGNON, O. AND SCHORDERET, M.: Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum. J Pharmacol. Exp. Ther. 266: 350-357, 1993.
18. PITCHER, J., LOHSE, M. J., CODINA, J., CARON, M. G. AND LEFKOWITZ, R. J.: Desensitization of the isolated β2-adrenergic receptor by β-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31: 3193-3197, 1992.
19. SIDHU, A. AND FISHMAN, P. H.: Identification and characterization of functional Dl dopamine receptors in a human neuroblastoma cell line. Biochem. Biophys. Res. Commun. 166: 675-579, 1990.
20. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag, New York, 1987.